Sylvia Cheung

CHIEF FINANCIAL OFFICER · ANIKA THERAPEUTICS, INC. · CIK 0001572857

FILING MIX · LIFETIME50%/50%

BUYS

SELLS

TOTAL VALUE

$60.7K

COMPANIES

ACTIVE SINCE

Feb 2020

HOLDINGS NOW

49,281

AVG SELL PX

$41.59

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Sylvia Cheung. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

ANIK · 49,281 shares · as of Feb 26, 2020

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 2 buys / 2 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED
ANIK ANIKA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	3,000	—	—	50,162	Feb 26, 2020	Feb 27, 2020 ↗
ANIK ANIKA THERAPEUTICS, INC.	SALE Chief Financial Officer	881	$42.25	$37.2K	49,281	Feb 26, 2020	Feb 27, 2020 ↗
ANIK ANIKA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	11,700	—	—	11,700	Feb 25, 2020	Feb 27, 2020 ↗
ANIK ANIKA THERAPEUTICS, INC.	SALE Chief Financial Officer	579	$40.59	$23.5K	47,162	Feb 4, 2020	Feb 6, 2020 ↗

Other insiders · ANIK

Loading peer insiders…

About this filer

CIK 0001572857

ROLE

Chief Financial Officer

PRIMARY

ANIK

COMPANIES

ACTIVE SINCE

Feb 2020

MARKETPEEL · /INSIDER/0001572857DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.